Even though CD44 is one of the NF-kB signature genes and a known marker for the discrimination between GCB and ABC DLBCL [153], this is the first report of MyD88L265P directly enhancing the expression and surface levels of CD44. The gene discussed is CD44; the disease is aneurysmal bone cyst.